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Abstract
Oncogene-induced senescence (OIS) can occur in response to hyperactive oncogenic signals and is believed to be a fail-safe
mechanism protecting against tumorigenesis. To identify new factors involved in OIS, we performed a screen for microRNAs
that can overcome or inhibit OIS in human diploid fibroblasts. This screen led to the identification of miR-378a-5p and in
addition several other miRNAs that have previously been shown to play a role in senescence. We show that ectopic
expression of miR-378a-5p reduces the expression of several senescence markers, including p16INK4A and senescence-
associated b-galactosidase. Moreover, cells with ectopic expression of miR-378a-5p retain proliferative capacity even in the
presence of an activated Braf oncogene. Finally, we identified several miR-378a-5p targets in diploid fibroblasts that might
explain the mechanism by which the microRNA can delay OIS. We speculate that miR-378a-5p might positively influence
tumor formation by delaying OIS, which is consistent with a known pro-oncogenic function of this microRNA.
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Introduction
Senescence is a permanent exit from the cell cycle that can be
driven by different cellular and environmental signals. Critical
shortening of telomeres, oxidative stress, DNA damage and
aberrant activation of certain oncogenes can all lead to cellular
senescence [1,2]. The latter case is termed oncogene induced
senescence (OIS) and is thought to function as a mechanism to
prevent tumorigenesis [3,4]. The presence of oncogenic
BRAFV600E, for example, results in senescence in vivo, which is
evident from senescent melanocytes that can be found in benign
human naevi [5].
Although the precise molecular pathway leading from the
activated oncogenes to the final growth arrest is not known, it
involves activation of the RAF-MEK-ERK kinase pathway that
results in transcriptional activation of the INK4A-ARF-INK4B
locus. This important tumor suppressor locus codes for 3 proteins
(p16INK4A, p15INK4B and p14ARF) that all are activated by cellular
stress and regulate cellular proliferation by feeding into the p53
and pRB tumor suppressor pathways [6]. Mouse cells depend on
both p19ARF-p53 and p16INK4A-pRB pathways during OIS.
However, in human cells it appears that p16INK4A plays a more
prominent role, as certain cell types only require p16INK4A
expression to induce senescence [7,8]. The importance of this
locus for senescence is also evident from the fact that among the
factors that have been identified to regulate OIS are several
proteins that regulate expression of the INK4A-ARF-INK4B locus,
including the Polycomb group protein BMI1 [9,10] and the
histone demethylase JMJD3 [11,12].
Recent results have shown the importance of senescence as a
tumor barrier in vivo. For instance, failure to clear senescent cells
after introduction of oncogenic Nras in the liver leads to increased
incidence of hepatocellular carcinoma [13]. The protective effect
involves immune surveillance and extensive communication of the
pre-malignant senescent cells with their environment, probably
through the acquisition of the senescence-associated secretory
phenotype (SASP) [13,14].
Several microRNAs (miRNAs) have also been shown to be
involved in senescence. miRNAs are transcribed, processed into
hairpin intermediates called pre-microRNAs (pre-miRs), and
cleaved to give mature 21–23 nucleotide long miRNAs that often
function by targeting the 39 untranslated region (UTR) of mRNA
transcripts, thereby downregulating the expression of their targets
[15]. miRNAs that can either induce or help cells to evade
senescence have been identified and they include miRNAs that
target the p53 pathway, the p16INK4A-pRB pathway and the SASP
[16,17].
To identify new factors involved in OIS, we performed a screen
for miRNAs that can overcome or inhibit OIS in human diploid
fibroblasts, using p16INK4A expression as a readout. We expressed
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a library of 471 human pre-miRs in human fibroblasts, which were
subsequently induced to senesce by activation of the Braf
oncogene [18]. Our screen identified several miRNAs that can
regulate senescence, among which miR-378a-5p (previously miR-
378 and miR-378*), a miRNA that is expressed in several types
of cancer and has oncogenic properties [19–23]. The introduction
of miR-378a-5p oligonucleotides resulted in reduced activation of
p16INK4A upon activation of Braf and allowed cells to retain
proliferative capacity even in the presence of the activated
oncogene. We furthermore identified putative miR-378a-5p target
mRNAs in human fibroblasts by high throughput RNA sequenc-
ing. Taken together our results suggest that miR-378a-5p can have
a positive effect on tumor formation by preventing full activation
of the senescence program. These results are in agreement with
the oncogenic features of miR-378a-5p
Results
Identification of miRNAs regulating OIS
To identify miRNAs with a role in OIS, we used the human
diploid fibroblast line TIG3, which was immortalized with
telomerase and expressed a conditional form of the mouse Braf
oncogene (DBraf:ER), that allows senescence to be induced by
treatment with 4-hydroxytamoxifen (4-OHT) [11,18]. Immuno-
fluorescent staining of p16INK4A was used as a measure for
senescence and the screen was essentially performed as follows:
cells were transfected on day 0, treated with 1 mM 4-OHT on day
2 and fixed for analysis on day 4 (Figure 1a). A library containing
471 human pre-miRs (miRNA mimics) was reverse transfected
into TIG3-hTERT-DBraf:ER cells and their effect on senescence
determined (Figure 1b). In addition to a scrambled control (SCR),
we used siRNAs against BMI1, INK4A and JMJD3 (BMI1i, p16i,
JMJD3i) as controls in every plate in the screen. Cells transfected
with the SCR control were treated with ethanol as a technical
control for the staining and image analysis procedure (SCR (-)
Figure 1). The behavior of the controls in each plate was
determined (Figure S1a). The control siRNAs included in the
screen (i.e. knockdown of BMI1 or JMJD3) have been shown to
play a biological role in senescence [9–12] and therefore all
miRNAs that performed better than the control siRNAs were
considered potential hits (listed miRNAs in Figure 1b). In the
screen we identified 16 miRNAs that had a positive effect on p16
expression and 7 miRNAs whose expression resulted in reduced
p16 levels. Images of controls and selected miRNAs are shown in
Figure 1c, pictures for all miRNAs considered hits are depicted in
Figures S2, S3). The fold change in percentage p16 positive cells
relative to each plate average was approximately 2.25 for hits
increasing (Figure 1d) and 5–10 fold for hits decreasing (Figure 1e)
the percentage of p16INK4A positive cells.
To validate the results from the screen, we designed miRNA
oligonucleotides that were used in all subsequent experiments. To
ensure incorporation of the desired strand into RISC, we designed
the miRNA oligonucleotides with a wobble at the 59 end of the
mature strand [24]. miRNAs indicated in bold font (Figure 1b)
were selected for validation. They were transfected in 96-well plate
format and analyzed by automated image analysis (Figure 1f). Out
of the selected potential hits miRNAs-30d, 429, 200c, 96, 649 and
378a-5p were successfully validated, and showed a significant
effect on p16INK4A levels after senescence induction compared to
the scrambled control (Figure 1f, asterisks). The miRNAs
increasing p16INK4A expression include 2 members of the miR-
200/429 family, of which miR-200c has been shown to be a
transcriptional target of p53 and to be involved in senescence
induction [25,26]. Interestingly, the miR-200/429 family can also
regulate several members of the polycomb family [27,28].
2 miRNAs miR-649 and miR-378a-5p that seemed to help cells
overcome senescence were identified. In this paper we have
focused on miR-378a-5p, because it was shown to be over
expressed in several cancer types and implicated in the develop-
ment and maintenance of cancer cells in vitro [19–23].
Increased expression of miR-378a-5p can partly
overcome OIS
Our immunofluorescence staining demonstrates that miR-378a-
5p is capable of reducing p16INK4A protein levels. Moreover, as
shown in Figures 2a,b, mir-378a-5b can also repress p16INK4A
mRNA and protein levels. Importantly, miR-378a-5p expression
does not alter the levels of Braf:ER. To determine whether cells
are still undergoing senescence in the presence of ectopically
expressed miR-378a-5p, we determined the levels of senescence
associated b-galactosidase (SA- bGAL; Figure 2c) and of several
other markers of senescence [7] (Figure 2d). Morphologically, cells
transfected with miR-378a-5p oligonucleotides were more similar
to the untreated (- 4-OHT) control cells than the spindle-shaped
morphology normally observed in fibroblast cells expressing
oncogenic Braf (Figure 2c and [5]). Moreover, the number of
SA- bGAL positive cells was reduced in cells transfected with miR-
378a-5p oligonucleotides as compared to control (Figure 2c).
Consistent with miR-378a-5p having a role in regulating
senescence, the induction of the senescence markers DEC1,
CXCL2 and IL1A was impaired in cells overexpressing miR-
378a-5p (Figure 2d). Though another tested marker, DCR2, was
not altered, these data show that the expression of miR-378a-5p is
sufficient to prevent cells from fully entering the senescence
program.
Since the definition of senescence is an irreversible arrest of
proliferation, we also determined the proliferation rate by BrdU
and EdU incorporation in these cells. We found that miR-378a-5p
transfected cells showed increased EdU incorporation, while at the
same time p16INK4A levels were reduced upon Braf activation
(Figure 2e) after 24 and 48 hours. This was confirmed by BrdU
incorporation assay after 48 hours, where only 0.13% of the SCR
control cells had incorporated BrdU vs 4.09% of the miR-378a-5p
expressing cells (Figure 2f). Taken together these results show that
miR-378a-5p expression can lead to a delay in execution of
oncogene-induced senescence.
Identification of potential miR-378-5p target mRNAs
miRNA genes are transcribed and in the process of generating
the mature miRNA, two distinct mature miRNAs can be formed
and become active. We measured the expression of both mature
miRNAs transcribed from the miR-378a gene, miR-378a-5p and
miR-378a-3p, by RT-qPCR analysis and found that both are
expressed at low levels in TIG3 cells (Figure 3a). We expected to
find miR-378a-5p at low levels, as it counteracts senescence, which
these cells can normally undergo upon receiving the appropriate
signals. In order to determine whether the effect we observe for
miR-378a-5p is specific to this miRNA, we expressed miR-378a-
3p oligonucleotides in TIG3-hTERT-DBraf:ER cells, which did
not result in decreased p16INK4A protein levels upon senescence
induction (Figure 3b) as compared to SCR control transfected cells
(Figure 2b).
Two targets of miR-378-5p as predicted by Targetscan 5.2 [29],
SP1 and SUFU, previously have been implicated in regulation of
p16INK4A [30,31]. Therefore, we tested whether their expression
was affected by miR-378a-5p in TIG3-hTERT-DBraf:ER cells,
and if their knockdown was sufficient to copy the phenotype
miR-378a-5p Inhibits Oncogene Induced Senescence
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Figure 1. Identification of miRNAs that affect p16INK4A expression during oncogene-induced senescence. (a) Graphical representation
of the workflow. The screen was performed in 384 well-format in TIG3 DBraf:ER cells with a library containing 471 human pre-miRs. 48 hours after
transfection the cells were treated with 4-hydroxy-tamoxifen (4-OHT) for 48 hours and p16INK4A levels were determined by immunofluorescense (IF)
and analyzed automatically. (b) Screen results. The percentage of p16INK4A positive cells was determined for each well using the Hoechst signal to
determine the total cell number. Following automated image analysis, the Z-score was calculated for each miRNA based on the average percentage
of p16INK4A positive cells per plate. All listed miRNAs are considered potential hits; the ones indicated in bold were chosen for further validation.
BMI1i, p16i and JMJD3i represent controls in which BMI1, p16INK4A or JMJD3 were downregulated by siRNAs. SCR: scrambled control. (-) indicates
scrambled control cells in which senescence was not induced. (c) Immunofluorescense images taken as part of the screening process. Controls and
selected hits are shown. (d) Fold change relative to the plate average of all hits increasing the percentage of p16INK4A positive cells in the screen (red
line indicates the overall average). (e) Fold change relative to the plate average of all hits decreasing the percentage of p16INK4A positive cells in the
screen (red line indicates the overall average). (f) The average of p16INK4A induction in 5 independent experiments. IF for p16INK4A followed by
automated image analysis was used as a readout and scrambled (SCR) control samples were used for normalization. Averages are shown with SEM
miR-378a-5p Inhibits Oncogene Induced Senescence
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observed upon miR-378a-5p over expression. However, we did not
find the two genes differentially expressed and knockdown of SUFU
or SP1 alone using 2 different siRNAs per gene or in combination
did not result in altered expression of p16INK4A in response to Braf
expression in TIG3 cells (Figure S4a, b). Therefore, the two genes
did not explain the effect of miR-378a-5p, and we used RNA
sequencing to identify genes whose expression was altered after
expressing miR-378a-5p.
Cells were transfected with miR-378a-5p oligonucleotides or
controls, and mRNA was extracted 48 hours after transfection.
mRNA of biological replicate samples were sequenced and
analyzed using TopHat and Cuffdiff [32]. We identified 309
and t-tests were used to evaluate differences. Asterisks indicate a significant difference (p,0.001) in p16INK4A induction.
doi:10.1371/journal.pone.0091034.g001
Figure 2. miR-378a-5p overexpression impairs oncogene-induced senescence. TIG3 DBraf:ER cells were transfected with scrambled control
(SCR) or miR-378a-5p or miR378a-3p and after 48 hours treated with 4-OHT (+) or ethanol (2). (a) RT-qPCR using the housekeeping gene RPLPO as a
reference and (b) western blot analysis of p16INK4A expression after 24 and 48 hours of senescence induction (c) Senescence-associated b-gal staining
after 48 hours of ethanol or 4-OHT treatment. (d) RT-qPCR analysis of the indicated senescence markers after 24 and 48 hours. Expression of RPLPO
was determined and used for normalization. (e) Quantification of EdU and p16INK4A staining of cells treated with ethanol or 4-OHT for 24 and
48 hours. Averages of 3 replicates are shown with the standard deviation. (f) Flow cytometric analysis of BrdU and propidium iodide staining of cells
treated with ethanol or 4-OHT for 48 hours.
doi:10.1371/journal.pone.0091034.g002
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genes that were upregulated (Figure 3c, table S1) and 227 genes
that were downregulated in response to miR-378a-5p expression
(Figure 3d, table S1). These differences in expression comprise
both primary and secondary effects. As miRNAs target their
mRNAs using a 6–8 nucleotide long seed sequence present in their
5 prime end, we overlapped the list of differentially expressed
genes with the predicted targets for miR-378a-5p (Figure 3e).
Downregulated genes containing a match for the seed-sequence of
miR-378a-5p with their relative fold change and false discovery
rates (q-values) are indicated in Figure 3e. We then validated the
expression changes in 3 independent biological replicates (Figure
S5a) and could confirm the downregulation by miR-378a-5p of 20
genes (GNPDA1, STAMBP, HNRNPA3, KLF9, PCBP2, TMUB2,
SLC7A11, LIMD1, RSAD1, TRIM44, KPNA1, VGLL3, HOOK3,
LATS2, KLF13, NDEL1, FOXN3, PLAU, ZZZ3 and MCFD2).
Though several of these have been described as potential tumor
suppressor genes, or to be downregulated in different tumor types
[33–42], the role of these proteins in senescence induction has not
been determined.
In addition to the targets that we identified by RNA sequencing,
miR-378a-5p has been shown to be involved in tumorigenesis and
tumor maintenance by regulating SUFU, TUSC2, TOB2,
GABPA and ESRRg [19–23]. In our RNA sequencing experi-
ment, the expression of these genes was not significantly altered
and we therefore analyzed their expression by RT-qPCR (Figure
S5b). Here again we found that they were not differentially
expressed upon miR-378a-5p expression, and it is therefore
unlikely that these genes contribute to regulating senescence in
TIG3-hTERT-DBraf:ER.
Discussion
The microRNA miR-378a-5p previously has been identified as
an oncogene, where it has been shown to function in different
pathways depending on the cell type studied. miR-378a-5p
enhances cell survival, proliferation rate and angiogenesis in
glioblastoma cells, through targeting of SUFU and TUSC2 [19].
In mammary cells, miR-378a is a transcriptional target of Myc, and
it regulates oncogenic transformation through the regulation of
TOB2 expression [20]. In addition, miR-378a-5p has been shown
to be involved in increasing cell proliferation of breast cancer cells
by mediating a metabolic shift. Through downregulation of
GABPA and ERRc, two PGC-1b partners, miR–378a–5p helps to
orchestrate the Warburg effect in breast cancer cells [21].
Here, we have shown that over expression of miR-378a-5p
allows human fibroblasts to escape the full senescence program
upon induction of oncogenic Braf. As the expression of none of the
previously published targets of miR-378a-5p is affected in TIG3
cells, they are most likely not involved here. Therefore we
performed experiments to identify 20 potential mRNA targets of
miR-378a-5p in human fibroblasts. Even though further experi-
ments will be required to determine the contribution of the 20
identified target genes in oncogene-induced senescence, we
hypothesize that one, or perhaps more likely, more than one of
these 20 putative miR-378a-5p target genes contribute to the
observed phenotype. In summary, we have shown that the
oncogenic microRNA miR-378a-5p can contribute to overriding
oncogene-induced senescence in vitro. Since senescence forms a
barrier against tumor formation in vivo, we speculate.that the
Figure 3. Identification of miR-378a-5p targets in TIG3 DBraf:ER cells. (a) Relative expression of miR-378a-5p and miR-378a-3p in TIG3
DBraf:ER cells during induction of senescence. miR-191 expression was used as a reference. (b) p16INK4A protein expression of TIG3 DBraf:ER cells
transfected with miR-378a-3p after 48 hours treatment with 4-OHT (+) or ethanol (2). (c) Venn diagram of genes significantly up regulated following
over expression of miR-378a-5p and all genes predicted to have the seed sequence in their 59UTR. (d) Venn diagram of genes significantly down
regulated following over expression of miR-378a-5p and all genes predicted to have the seed sequence in their 59UTR. (e) List of 19 genes
significantly down regulated and containing the miR-378a-5p seed sequence. Their fold-change and false discovery rate (q-value) are indicated. RNA
sequencing was used to measure gene expression.
doi:10.1371/journal.pone.0091034.g003
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observed effect on senescence induction could provide miR-378a-
5p with an additional mechanism for how it is involved in
tumorigenesis.
Materials and Methods
Cell culture and siRNA transfections
The human diploid cell line TIG3 (from the Japanese Cancer
Research Resources Bank, Tokyo, Japan) was immortalized with
telomerase (hTERT) and transduced with a retrovirus generated
from pMSCVblast-DBraf:ER in order to be able to induce
senescence [11,18]. Cells were maintained in DMEM (Gibco)
supplemented with 10% FBS (Hyclone) and penicillin/streptomy-
cin (Gibco). Senescence was induced by treatment with 1 mM 4-
hydroxytamoxifen (4-OHT, Sigma) from a 1 mM stock in 96%
ethanol. As a control, cells were treated with ethanol alone.
siRNA and miRNA oligonucleotides were introduced into
TIG3 cells at a final concentration of 50 nM by reverse
transfection using Lipofectamine 2000 (Invitrogen) according to
the manufacturer’s instructions. The siRNAs and miRNA
oligonucleotides that were used are listed in table S2.
siRNA screen and p16INK4A immunofluoresence
The screen was performed using a human-pre-miR-library
containing 471 human pre-miRs (Ambion). TIG3-hTERT-
DBraf:ER cells were reverse transfected in quadruplicates in
384-well plates and after 48 hours treated with 1 mM of 4-OHT
for an additional 48 hours. Each plate contained cells transfected
with control siRNAs (scrambled, JMJD3i, BMI1i). Cells were fixed
by adding an equal volume of 4% formaldehyde to the wells, after
which they were permeabilized with Triton-x-100 and stained
with p16INK4A antibody (sc-56330, Santa Cruz) and Hoechst
33258 (Invitrogen). Automated image analysis was performed on
the INCell Analyzer 1000 (GE Healthcare) using a 206 objective
and 6 images per well (containing approximately 100 cells per
image) and the percentage of p16INK4A positive cells per image
determined using the INCell Analyzer Workstation 3.6 software
(GE Healthcare). The Hoechst signal was used to determine the
total cell number in each image and the p16INK4A values of the 6
images were averaged for further analysis. For hit determination,
Z-scores were calculated for each well using the respective plate
averages (Figure S1b).
Antibodies for Western blotting
The following antibodies were used in Western blot analysis:
p16INK4A (DCS50), DBraf:ER (sc-166 Santa Cruz) and b-actin
(Ab6276 Abcam)
Senescence associated b-galactosidase staining
Senescence associated b-galactosidase staining was performed as
previously described [43].
BrdU and EdU incorporation assays
Cells were pulsed with 33 mM BrdU or 8 mM EdU for 3 hours
prior to fixation. BrdU treated cells were fixed and stained with an
antibody against BrdU (Beckson & Dickinson) and propidium
iodide (Sigma), after which they were analyzed by flow cytometry
using a FACSCalibur (BD biosciences). EdU treated cells, which
were grown in 96-well plates, were fixed and stained for p16INK4A
as described above. EdU was detected using Click-IT EdU
chemistry (Invitrogen) according to manufacturer’s protocol and
automated image analysis as described above.
RNA extraction and RT-qPCR
RNA for mRNA expression analysis was extracted using the
RNeasy Plus kit (Qiagen) and reverse transcribed using Taqman
reverse transcription reagents (Applied Biosystems). Quantitative
PCR was done on a LightCycler480 (Roche), using LightCycler
480 SYBR Green I Master mix (Roche). Primer sequences are
listed in table S3. RNA for miRNA expression analysis was
extracted with the miRNeasy kit (Qiagen), reverse transcribed with
Taqman MicroRNA reverse transcription kit (Applied biosystems)
and quantified using Taqman MicroRNA assays for miR-191
(assay ID 002299), miR-378-3p (assay ID 002243) and miR-378-
5p (assay ID 000567). Differences in expression were determined
using the 22DDCt method [44], using the housekeeping gene
RPLP0 and miR-191 for normalization.
RNA sequencing
TIG3-hTERT-DBraf:ER cells were transfected with scrambled
control or miR-378-5p oligonucleotides. 48 hours after transfec-
tion, RNA was extracted from 3 biological replicates, it’s quality
monitored on the 2100 expert Bioanalyzer (Agilent), and prepared
for sequencing using the NEBNext mRNA sample Prep Master
Mix Set 1(New England Biolabs). The amplified cDNA was
analyzed by Solexa/Illumina high-throughput sequencing. The
tags were mapped to the human genome (assembly hg19) with
TopHat [45] and differential expression was determined with
Cufflinks [32] at an FDR cut-off value ,0.5.
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